IPA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Immunoprecise Antibodies Ltd (IPA).


$33.68M Market Cap.

As of 07/29/2024 5:00 PM ET (MRY) • Disclaimer

IPA Market Cap. (MRY)


IPA Shares Outstanding (MRY)


IPA Assets (MRY)


Total Assets

$59.99M

Total Liabilities

$26.07M

Total Investments

$0

IPA Income (MRY)


Revenue

$24.52M

Net Income

-$27.18M

Operating Expense

$41.18M

IPA Cash Flow (MRY)


CF Operations

-$4.25M

CF Investing

-$1.56M

CF Financing

$1.02M

IPA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

IPA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$59,988,000 (-22.91%)

$77,813,000 (-16.91%)

$93,647,000 (39.86%)

$66,959,000 (145.60%)

Assets Current

$11,487,000 (-31.59%)

$16,792,000 (-55.19%)

$37,470,000 (-23.31%)

$48,858,000 (534.60%)

Assets Non-Current

$48,501,000 (-20.52%)

$61,021,000 (8.62%)

$56,177,000 (210.35%)

$18,101,000 (-7.48%)

Goodwill & Intangible Assets

$31,244,000 (-37.63%)

$50,096,000 (-3.71%)

$52,025,000 (276.04%)

$13,835,000 (-14.57%)

Shareholders Equity

$33,921,000 (-41.32%)

$57,803,000 (-23.22%)

$75,285,000 (32.26%)

$56,924,000 (277.33%)

Property Plant & Equipment Net

$16,696,000 (60.66%)

$10,392,000 (191.99%)

$3,559,000 (-11.56%)

$4,024,000 (30.73%)

Cash & Equivalents

$3,545,000 (-57.63%)

$8,366,000 (-72.16%)

$30,047,000 (-28.18%)

$41,838,000 (1454.74%)

Accumulated Other Comprehensive Income

$2,025,000 (-22.86%)

$2,625,000 (205.89%)

-$2,479,000 (-260.84%)

-$687,000 (-129.00%)

Deferred Revenue

$1,352,000 (38.38%)

$977,000 (-5.51%)

$1,034,000 (-6.93%)

$1,111,000 (-24.68%)

Total Investments

$0 (0%)

$115,000 (-19.01%)

$142,000 (27.93%)

$111,000 (-6.72%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$115,000 (-19.01%)

$142,000 (27.93%)

$111,000 (-6.72%)

Inventory

$2,139,000 (3.83%)

$2,060,000 (27.55%)

$1,615,000 (34.14%)

$1,204,000 (47.01%)

Trade & Non-Trade Receivables

$277,000 (-56.17%)

$632,000 (0.48%)

$629,000 (-82.66%)

$3,628,000 (-0.87%)

Trade & Non-Trade Payables

$4,372,000 (29.12%)

$3,386,000 (-28.98%)

$4,768,000 (58.35%)

$3,011,000 (70.50%)

Accumulated Retained Earnings (Deficit)

-$100,265,000 (-37.18%)

-$73,088,000 (-57.08%)

-$46,528,000 (-56.03%)

-$29,819,000 (-32.65%)

Tax Assets

$414,000 (-22.76%)

$536,000 (93.50%)

$277,000 (-43.58%)

$491,000 (457.95%)

Tax Liabilities

$6,378,000 (-16.77%)

$7,663,000 (-10.44%)

$8,556,000 (336.98%)

$1,958,000 (22.30%)

Total Debt

$13,681,000 (88.26%)

$7,267,000 (162.63%)

$2,767,000 (-19.96%)

$3,457,000 (-23.33%)

Debt Current

$1,563,000 (40.05%)

$1,116,000 (-51.46%)

$2,299,000 (133.16%)

$986,000 (-65.69%)

Debt Non-Current

$12,118,000 (97.01%)

$6,151,000 (1214.32%)

$468,000 (-81.06%)

$2,471,000 (51.13%)

Total Liabilities

$26,067,000 (30.27%)

$20,010,000 (8.98%)

$18,362,000 (82.98%)

$10,035,000 (-17.59%)

Liabilities Current

$8,124,000 (37.23%)

$5,920,000 (-36.29%)

$9,292,000 (53.03%)

$6,072,000 (-23.43%)

Liabilities Non-Current

$17,943,000 (27.35%)

$14,090,000 (55.35%)

$9,070,000 (128.87%)

$3,963,000 (-6.69%)

IPA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$24,518,000 (18.65%)

$20,665,000 (6.72%)

$19,364,000 (8.11%)

$17,912,000 (27.41%)

Cost of Revenue

$12,465,000 (36.95%)

$9,102,000 (8.60%)

$8,381,000 (31.49%)

$6,374,000 (5.81%)

Selling General & Administrative Expense

$19,135,000 (-18.30%)

$23,420,000 (29.71%)

$18,055,000 (125.60%)

$8,003,000 (22.71%)

Research & Development Expense

$4,043,000 (-67.08%)

$12,280,000 (60.25%)

$7,663,000 (288.20%)

$1,974,000 (342.60%)

Operating Expenses

$41,177,000 (2.65%)

$40,114,000 (44.65%)

$27,731,000 (50.25%)

$18,457,000 (52.19%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$517,000 (-3.72%)

Income Tax Expense

-$1,526,000 (-28.02%)

-$1,192,000 (-238.44%)

$861,000 (-35.99%)

$1,345,000 (488.73%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$27,177,000 (-2.32%)

-$26,560,000 (-58.96%)

-$16,709,000 (-127.64%)

-$7,340,000 (-48.37%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$27,177,000 (-2.32%)

-$26,560,000 (-58.96%)

-$16,709,000 (-127.64%)

-$7,340,000 (-48.37%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$27,177,000 (-2.32%)

-$26,560,000 (-58.96%)

-$16,709,000 (-127.64%)

-$7,340,000 (-48.37%)

Weighted Average Shares

$25,635,526 (2.97%)

$24,897,185 (26.46%)

$19,688,487 (19.51%)

$16,474,350 (20.88%)

Weighted Average Shares Diluted

$25,635,526 (2.97%)

$24,897,185 (26.46%)

$19,688,487 (19.51%)

$16,474,350 (20.88%)

Earning Before Interest & Taxes (EBIT)

-$28,703,000 (-3.43%)

-$27,752,000 (-75.11%)

-$15,848,000 (-189.30%)

-$5,478,000 (-15.18%)

Gross Profit

$12,053,000 (4.24%)

$11,563,000 (5.28%)

$10,983,000 (-4.81%)

$11,538,000 (43.61%)

Operating Income

-$29,124,000 (-2.01%)

-$28,551,000 (-70.47%)

-$16,748,000 (-142.06%)

-$6,919,000 (-69.00%)

IPA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$1,563,000 (20.54%)

-$1,967,000 (62.23%)

-$5,208,000 (-112.05%)

-$2,456,000 (-55.15%)

Net Cash Flow from Financing

$1,021,000 (264.41%)

-$621,000 (-121.54%)

$2,883,000 (-93.35%)

$43,379,000 (24830.46%)

Net Cash Flow from Operations

-$4,246,000 (78.59%)

-$19,833,000 (-99.91%)

-$9,921,000 (-1553.50%)

-$600,000 (56.87%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$4,788,000 (78.65%)

-$22,421,000 (-83.09%)

-$12,246,000 (-130.37%)

$40,323,000 (1540.11%)

Net Cash Flow - Business Acquisitions and Disposals

-$25,000 (95.12%)

-$512,000 (86.13%)

-$3,692,000 (-258.79%)

-$1,029,000 (-2.18%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$1,397,000 (6.56%)

-$1,495,000 (-18.93%)

-$1,257,000 (11.91%)

-$1,427,000 (-147.74%)

Issuance (Repayment) of Debt Securities

-$1,339,000 (-0.15%)

-$1,337,000 (-38.98%)

-$962,000 (-24.61%)

-$772,000 (-142.01%)

Issuance (Purchase) of Equity Shares

$2,360,000 (229.61%)

$716,000 (-81.40%)

$3,850,000 (-91.28%)

$44,151,000 (8855.58%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,535,000 (-21.00%)

$1,943,000 (-36.98%)

$3,083,000 (12.19%)

$2,748,000 (271.85%)

Depreciation Amortization & Accretion

$5,754,000 (-14.31%)

$6,715,000 (74.23%)

$3,854,000 (-5.05%)

$4,059,000 (-5.76%)

IPA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

49.20% (-12.14%)

56.00% (-1.23%)

56.70% (-11.96%)

64.40% (12.78%)

Profit Margin

-110.80% (13.77%)

-128.50% (-48.90%)

-86.30% (-110.49%)

-41.00% (-16.48%)

EBITDA Margin

-93.60% (8.06%)

-101.80% (-64.46%)

-61.90% (-683.54%)

-7.90% (-146.88%)

Return on Average Equity (ROAE)

-57.30% (-33.26%)

-43.00% (-47.77%)

-29.10% (-39.23%)

-20.90% (29.87%)

Return on Average Assets (ROAA)

-37.40% (-13.68%)

-32.90% (-35.39%)

-24.30% (-55.77%)

-15.60% (12.36%)

Return on Sales (ROS)

-117.10% (12.81%)

-134.30% (-64.18%)

-81.80% (-167.32%)

-30.60% (9.47%)

Return on Invested Capital (ROIC)

-103.70% (40.02%)

-172.90% (34.26%)

-263.00% (-296.68%)

-66.30% (61.70%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-1.67 (48.24%)

-3.22 (60.94%)

-8.24 (69.10%)

-26.68

Price to Sales Ratio (P/S)

1.85 (-55.48%)

4.15 (-41.75%)

7.12 (-35.49%)

11.04

Price to Book Ratio (P/B)

1.37 (-7.87%)

1.49 (-17.89%)

1.81 (-49.20%)

3.56

Debt to Equity Ratio (D/E)

0.77 (121.97%)

0.35 (41.80%)

0.24 (38.64%)

0.18 (-78.19%)

Earnings Per Share (EPS)

-1.06 (0.93%)

-1.07 (-25.88%)

-0.85 (-88.89%)

-0.45 (-25.00%)

Sales Per Share (SPS)

0.69 (11.95%)

0.62 (-20.74%)

0.78 (-11.65%)

0.88 (20.77%)

Free Cash Flow Per Share (FCFPS)

-0.22 (74.33%)

-0.86 (-50.88%)

-0.57 (-361.79%)

-0.12 (14.58%)

Book Value Per Share (BVPS)

1.32 (-43.02%)

2.32 (-39.28%)

3.82 (10.68%)

3.46 (212.10%)

Tangible Assets Book Value Per Share (TABVPS)

1.12 (0.72%)

1.11 (-47.35%)

2.11 (-34.45%)

3.23 (297.17%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (33.33%)

-3 (57.14%)

-7 (80.00%)

-35

Enterprise Value Over EBITDA (EV/EBITDA)

-2.38 (38.95%)

-3.9 (56.04%)

-8.88 (93.40%)

-134.53

Asset Turnover

0.34 (31.64%)

0.26 (-9.22%)

0.28 (-26.18%)

0.38 (-24.36%)

Current Ratio

1.41 (-50.14%)

2.84 (-29.68%)

4.03 (-49.88%)

8.05 (728.63%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$5,643,000 (73.54%)

-$21,328,000 (-90.80%)

-$11,178,000 (-451.46%)

-$2,027,000 (-3.05%)

Enterprise Value (EV)

$39,640,886 (-35.34%)

$61,310,477 (-27.50%)

$84,569,060 (-45.51%)

$155,201,559

Earnings Before Tax (EBT)

-$28,703,000 (-3.43%)

-$27,752,000 (-75.11%)

-$15,848,000 (-164.35%)

-$5,995,000 (-13.26%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$22,949,000 (-9.09%)

-$21,037,000 (-75.40%)

-$11,994,000 (-745.24%)

-$1,419,000 (-216.04%)

Invested Capital

$30,756,000 (48.59%)

$20,698,000 (309.86%)

$5,050,000 (-41.76%)

$8,671,000 (74.92%)

Working Capital

$3,363,000 (-69.07%)

$10,872,000 (-61.42%)

$28,178,000 (-34.14%)

$42,786,000 (18622.08%)

Tangible Asset Value

$28,744,000 (3.71%)

$27,717,000 (-33.41%)

$41,622,000 (-21.65%)

$53,124,000 (379.93%)

Market Capitalization

$33,683,533 (-47.50%)

$64,161,201 (-40.70%)

$108,204,216 (-34.42%)

$164,986,515

Average Equity

$47,404,000 (-23.19%)

$61,716,750 (7.66%)

$57,327,750 (63.59%)

$35,044,174 (111.40%)

Average Assets

$72,716,500 (-9.93%)

$80,737,250 (17.50%)

$68,715,000 (46.45%)

$46,920,489 (68.40%)

Invested Capital Average

$27,666,500 (72.32%)

$16,055,500 (166.40%)

$6,026,750 (-27.01%)

$8,257,212 (200.60%)

Shares

26,315,260 (5.41%)

24,965,448 (28.28%)

19,461,190 (15.13%)

16,904,356 (20.88%)